Search results
Dimitrios Tziakas
Research Area(s) / Expertise:
Author
Robin Ray
Research Area(s) / Expertise:
Job title: Consultant Cardiologist, Head of Education & Honorary Senior Lecturer
Author
Marco Valgimigli
Research Area(s) / Expertise:
Job title: Deputy Chief of Cardiology
Author
Peter H Brubaker
Research Area(s) / Expertise:
Job title: Professor in the Department of Health and Exercise Science and Executive Director of Healthy Exercise and Lifestyle ProgramS (HELPS)
Author
Melanie Maytin
Job title: Clinical Electrophysiology Fellow
Author
Stefan Verheye
Job title: Interventional Cardiologist
Author
Comparison of Haemodynamic Responses to Landiolol Versus Esmolol
Author(s):
Georgios Koukoulitsios
,
Kyriaki Tsikritsaki
,
Georgios Magklaras
,
et al
Added:
11 months ago
Original Research
Added:
1 month ago
Source:
CFR Journal Radcliffe Cardiology
A prespecified, secondary analysis of the MAPLE-HCM trial has shown that aficamten monotherapy provides superior and rapid benefits across multiple domains of disease burden compared with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).¹ Aficamten is a next-in-class cardiac myosin inhibitor (CMI) designed to reduce myocardial hypercontractility by decreasing…
View more
Archana Rao
Research Area(s) / Expertise:
Job title: Consultant Cardiologist
Author